Cargando…
Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
BACKGROUND: Meningiomas are the most common primary tumors of the central nervous system. In patients with WHO grade I meningiomas no adjuvant therapy is recommended after resection. In case of anaplastic meningiomas (WHO grade III), adjuvant fractionated radiotherapy is generally recommended, regar...
Autores principales: | Hemmati, Saman Moritz, Ghadjar, Pirus, Grün, Arne, Badakhshi, Harun, Zschaeck, Sebastian, Senger, Carolin, Acker, Güliz, Misch, Martin, Budach, Volker, Kaul, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719347/ https://www.ncbi.nlm.nih.gov/pubmed/31477146 http://dx.doi.org/10.1186/s13014-019-1368-z |
Ejemplares similares
-
Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma
por: Zschaeck, Sebastian, et al.
Publicado: (2018) -
Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
por: Badakhshi, Harun, et al.
Publicado: (2018) -
Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016) -
Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer
por: Kaul, David, et al.
Publicado: (2015) -
Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
por: Alfredo, Conti, et al.
Publicado: (2019)